Cippoint Nt Probnp Fast Test Kit 25

Cippoint Nt Probnp 25 Fast Test Kit is used for providing quantitative detection of NT-proBNP levels to help support the evaluation of heart function. It uses an immunofluorescence assay to provide reliable results and is compatible with various Getein analysers. It may help promote early assessment, monitor treatment response and support risk evaluation in individuals showing signs of cardiac dysfunction.

• Product Name: Cippoint Nt Probnp 25 Fast Test Kit
   
• Test Type: Quantitative Immunofluorescence Assay
   
• Analyte Detected: NT-proBNP (N-terminal B-type natriuretic peptide precursor)
   
• Sample Types: Human serum, plasma or whole blood
   
• Applicable Devices: Getein1100, Getein1160, Getein1180, Getein1200, Getein1600 and Getein208 (Hand-held Integrated System)
   
• Storage Conditions: 4°C–30°C
   
• Shelf Life: 24 months from the date of manufacture
   
• Testing Time After Opening (Pouch/Cartridge): 1 hour for foil pouches (Getein1100, 1160, 1180, 208)
   
• 24 hours if the cartridge (Getein1200, 1600) is opened and exposed to air
   
• 7 days if resealed properly in a foil pouch after partial use

• Early Evaluation of Heart Function: This test kit detects NT-proBNP levels, which may help support the evaluation of cardiac stress caused by volume or pressure overload in the left ventricle.
   
• Monitoring of Heart Failure Status: It helps support clinical assessments in individuals with suspected or existing heart failure by measuring NT-proBNP, a widely recognised cardiac biomarker.
   
• Risk Assessment in Acute Coronary Syndrome: By quantifying NT-proBNP levels, the kit may help promote cardiac risk evaluation in individuals with suspected acute coronary syndrome.
   
• Differentiation of Dyspnea Causes: The test may help identify whether shortness of breath is related to cardiac conditions like heart failure or non-cardiac issues.
   
• Prognostic Evaluation of Cardiac Conditions: It may help support clinicians in estimating the prognosis of individuals with cardiac dysfunction, enabling more personalised monitoring plans.
   
• Assessment of Treatment Response: This test kit can help support the monitoring of responses to medical interventions in heart failure, offering data that may help with therapy adjustments.

• Refer to the instruction manual provided with the kit for detailed usage directions.

• Follow the user manual carefully. 
• This kit is intended for in vitro diagnostic use only and should not be used internally or for therapeutic purposes.
• Do not use the test card beyond its expiration date.
• Avoid using damaged foil pouches or cartridges, as compromised packaging may affect test accuracy.
• Open the pouch or cartridge only when ready to perform the test and use it within the recommended time frame.
• Do not reuse any test components, including the test card and pipet.
• Handle all human specimens as potentially infectious; follow proper biosafety and waste disposal protocols.